Related Experiment Videos
[The use of Topisolone in dermatoses]
Zeitschrift Fur Hautkrankheiten
|January 1, 1975
Summary
Topisolon (Desoximetasone) demonstrated rapid efficacy in treating various dermatoses, achieving good results in 88% of patients within 14 days. This potent corticosteroid showed minimal side effects, making it a promising option for skin condition management.
Area of Science:
- Dermatology
- Pharmacology
Context:
- Topisolon (Desoximetasone) evaluated in a clinical trial involving 42 patients.
- Comparative study on symmetrical areas assessing topical corticosteroid efficacy.
Purpose:
- To evaluate the efficacy and safety of Topisolon (Desoximetasone) compared to triamcinolone acetonide.
- To assess the onset and degree of action of Topisolon in dermatoses treatment.
Summary:
- Topisolon exhibited a rapid onset of action, with 88% of patients showing good results after 14 days.
- Effective in treating psoriasis vulgaris, atopic dermatitis, and lichen ruber.
- Minimal adverse effects observed, with one case of candidiasis; no impact on blood glucose levels in diabetic patients.
Impact:
- Topisolon presents a favorable efficacy and safety profile for managing acute and chronic dermatoses.
- Provides a valuable therapeutic option for common skin conditions.
- Supports the use of Desoximetasone as a first-line treatment in dermatology.